Drug
Selatogrel
Selatogrel: highest development phase Phase 3, developed by Viatris. 3 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Viatris
Trials
| Drug | Phase | Indication |
|---|---|---|
| Selatogrel NCT04957719 | Phase 3 | Acute Myocardial Infarction |
| Selatogrel NCT03384966 | Phase 2 | Stable Coronary Artery Disease |
| Selatogrel NCT07615868 | Phase 1 | Chronic Coronary Syndrome |
Latest
No recent events.
Follow Selatogrel on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.